Evidence map›Paper›PMID 29983618›Full record

ReviewJournal of ginseng research2018

Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability.

Hyeongmin Kim, Jong Hyuk Lee, Jee Eun Kim, Young Su Kim, Choong Ho Ryu, Hong Joo Lee, Hye Min Kim, Hyojin Jeon, Hyo-Joong Won, Ji-Yun Lee and 1 more

Abstract readReview
In one paragraph

Review in Journal of ginseng research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Ginsenosides fromJournal of ginseng research · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hyeongmin KimCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Jong Hyuk LeeDepartment of Pharmaceutical Engineering, College of Life and Health Sciences, Hoseo University, Asan, Republic of Korea.
Jee Eun KimGraduate School of Pharmaceutical Management, Chung-Ang University, Seoul, Republic of Korea.
Young Su KimGraduate School of Pharmaceutical Management, Chung-Ang University, Seoul, Republic of Korea.
Choong Ho RyuGraduate School of Pharmaceutical Management, Chung-Ang University, Seoul, Republic of Korea.
Hong Joo LeeGraduate School of Pharmaceutical Management, Chung-Ang University, Seoul, Republic of Korea.
Hye Min KimGraduate School of Pharmaceutical Management, Chung-Ang University, Seoul, Republic of Korea.
Hyojin JeonCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Hyo-Joong WonCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Ji-Yun LeeCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea.
Jaehwi LeeCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenosides, dammarane-type triterpene saponins obtained from ginseng, have been used as a natural medicine for many years in the Orient due to their various pharmacological activities. However, the therapeutic potential of ginsenosides has been largely limited by the low bioavailability of the natural products caused mainly by low aqueous solubility, poor biomembrane permeability, instability in the gastrointestinal tract, and extensive metabolism in the body. To enhance the bioavailability of ginsenosides, diverse micro-/nano-sized delivery systems such as emulsions, polymeric particles, and vesicular systems have been investigated. The delivery systems improved the bioavailability of ginsenosides by enhancing solubility, permeability, and stability of the natural products. This mini-review aims to provide comprehensive information on the micro-/nano-sized delivery systems for increasing the bioavailability of ginsenosides, which may be helpful for designing better delivery systems to maximize the versatile therapeutic potential of ginsenosides.

Indexed as

bioavailabilitydelivery systemginsenosidespermeabilitysolubility

Identifiers

PMID29983618
PMCPMC6026383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.